Retrospective chart review of Mantle Cell Lymphoma patients who progressed on Acalabrutinib
Latest Information Update: 09 Jan 2021
At a glance
- Drugs Acalabrutinib (Primary)
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
Most Recent Events
- 08 Dec 2020 Results (n=26) presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology
- 29 Jan 2019 New trial record
- 04 Dec 2018 Results presented at the 60th Annual Meeting and Exposition of the American Society of Hematology